02

In a clinical trial, participants were given an antibody to CD117, a cell surface marker, in an effort to wipe out their defective blood stem cells without high-risk chemotherapy or radiation.

A perspective piece from Stanford scientists provides an overview of the value of precision health, its progress, challenges and how it can improve health at the individual and population level.

The winter issue of Stanford Medicine magazine highlights science that pushes boundaries to save lives and considers ethical questions that are a fundamental part of research.

Mentally running through a routine improves performance, but how that works isn’t clear. Now, a new tool — brain-machine interface — suggests the answer lies in how our brains prepare for action.

In a highly comprehensive meta-analysis of more than 500 clinical trials, researchers from around the world have drawn conclusions about the efficacy of 21 different antidepressants.

The five-year awards from the Chan Zuckerberg Initiative will help fuel research into the biology of neurodegenerative diseases. The awards honor a Stanford neuroscientist who died in December.

Iron enables a common mold to take root in lung transplant recipients, according to Stanford researchers who led a study that offers a new perspective for understanding and treating these pulmonary infections.

Many infectious diseases, including malaria, are marked by cyclical ups and downs. David Schneider takes a creative approach to making sense of those ups and downs.

The two-day conference at Stanford will bring together experts from academia, industry and government to discuss drug policy, research and business opportunities.

Gerald Reaven’s decades of research at Stanford helped show that insulin resistance could lead to Type 2 diabetes and multiple other diseases.